Jiuxia Pang

Author PubWeight™ 17.01^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1.	Blood	2009	5.87
2	Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.	Cancer Cell	2010	2.37
3	Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NF-kappaB-dependent DNA methyltransferase activity in acute myeloid leukemia.	Blood	2007	2.15
4	Transferrin receptor-targeted lipid nanoparticles for delivery of an antisense oligodeoxyribonucleotide against Bcl-2.	Mol Pharm	2009	1.37
5	A LC-MS/MS method for the analysis of intracellular nucleoside triphosphate levels.	Pharm Res	2009	1.07
6	Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.	J Pharmacol Exp Ther	2007	1.06
7	Phase I study of GTI-2040, an antisense to ribonucleotide reductase, in combination with high-dose cytarabine in patients with acute myeloid leukemia.	Clin Cancer Res	2008	1.05
8	Modulation of DNA methylation by a sesquiterpene lactone parthenolide.	J Pharmacol Exp Ther	2009	0.99
9	Targeted delivery of antisense oligodeoxynucleotide by transferrin conjugated pH-sensitive lipopolyplex nanoparticles: a novel oligonucleotide-based therapeutic strategy in acute myeloid leukemia.	Mol Pharm	2010	0.87
10	CD33-Targeted Lipid Nanoparticles (aCD33LNs) for Therapeutic Delivery of GTI-2040 to Acute Myelogenous Leukemia.	Mol Pharm	2015	0.75